NCT03188848View on ClinicalTrials.gov

Dose Escalating Study of BPI-3016 in Healthy Subjects

PHASE1UnknownINTERVENTIONAL
Enrollment

63

Participants

Timeline

Start Date

May 24, 2017

Primary Completion Date

July 31, 2019

Study Completion Date

December 31, 2019

Conditions
Healthy Subject
Interventions
DRUG

BPI-3016

Single-dose subcutaneous injection of BPI-3016

DRUG

Placebo

Single-dose subcutaneous injection of placebo to match BPI-3016

Trial Locations (1)

100005

RECRUITING

Beijing Hospital, Beijing

Sponsors
All Listed Sponsors
lead

Betta Pharmaceuticals Co., Ltd.

INDUSTRY

NCT03188848 - Dose Escalating Study of BPI-3016 in Healthy Subjects | Biotech Hunter | Biotech Hunter